Product Information
HALOPERIDOL 20 MG TABLET is a generic product labeled by Lifestar Pharma LLC, priced at $0.3711 per EA under NDC 70756023611. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Apr 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756023611
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOLApproval Type
Generic (ANDA)
FDA Application
ANDA216918FDA Approved
4/11/2024
TE Code
AB
On Market Since
4/11/2024
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL 20 MG TABLET has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3711 per EA |
|---|---|
| All-time high | $0.5994 (Nov 13, 2024) |
| All-time low | $0.2669 (Mar 18, 2026) |
| 52-week high | $0.3749 |
| 52-week low | $0.2669 |
| Median price | $0.3766 |
| Average price | $0.4190 |
| Largest weekly change | +35.9% (Aug 21, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the haloperidol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
haloperidol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL 20 MG TABLET, manufactured by Lifestar Pharma LLC, is $0.3711 per EA (NDC 70756023611), effective Sep 30, 2026.
How has the price of HALOPERIDOL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL 20 MG TABLET has declined 24.5%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL 20 MG TABLET?
Since Jul 10, 2024, the NADAC for HALOPERIDOL 20 MG TABLET has ranged from a low of $0.2669 (Mar 18, 2026) to a high of $0.5994 (Nov 13, 2024), with a median of $0.3766 per EA.
Are there cheaper alternatives to HALOPERIDOL 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HALOPERIDOL 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HALOPERIDOL 20 MG TABLET?
HALOPERIDOL 20 MG TABLET (NDC 70756023611) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.